Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
308.44
+15.03 (5.12%)
Dec 20, 2024, 4:00 PM EST - Market closed
Madrigal Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 232.68 | 99.92 | 331.55 | 36.27 | 54 | 46.7 | Upgrade
|
| Short-Term Investments | 765.94 | 534.22 | 27.23 | 234.08 | 230.15 | 392.35 | Upgrade
|
| Cash & Short-Term Investments | 998.63 | 634.13 | 358.77 | 270.35 | 284.15 | 439.05 | Upgrade
|
| Cash Growth | 329.79% | 76.75% | 32.71% | -4.86% | -35.28% | -9.24% | Upgrade
|
| Receivables | 30.46 | - | - | - | - | - | Upgrade
|
| Prepaid Expenses | 20.86 | 3.15 | 2.6 | 1.34 | 1.01 | 1.15 | Upgrade
|
| Total Current Assets | 1,064 | 637.28 | 361.37 | 271.68 | 285.16 | 440.2 | Upgrade
|
| Property, Plant & Equipment | 4.78 | 3.27 | 1.2 | 1.65 | 1.83 | 1.86 | Upgrade
|
| Total Assets | 1,073 | 640.55 | 362.57 | 273.33 | 287 | 442.06 | Upgrade
|
| Accounts Payable | 45.97 | 28.04 | 23.83 | 21.38 | 1.02 | 1.18 | Upgrade
|
| Accrued Expenses | 131 | 89.98 | 91.46 | 55.05 | 45.22 | 23.64 | Upgrade
|
| Current Portion of Leases | 0.88 | 0.53 | 0.6 | 0.41 | 0.32 | 0.32 | Upgrade
|
| Total Current Liabilities | 177.85 | 118.55 | 115.89 | 76.84 | 46.56 | 25.13 | Upgrade
|
| Long-Term Debt | 117.09 | 115.48 | 49.29 | - | - | - | Upgrade
|
| Long-Term Leases | 1.18 | 1.19 | - | 0.39 | 0.47 | 0.36 | Upgrade
|
| Total Liabilities | 296.11 | 235.21 | 165.18 | 77.23 | 47.03 | 25.49 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 2,519 | 1,741 | 1,160 | 863.5 | 665.39 | 639.57 | Upgrade
|
| Retained Earnings | -1,743 | -1,336 | -962.66 | -667.31 | -425.46 | -223.22 | Upgrade
|
| Comprehensive Income & Other | 1.27 | 0.47 | -0.03 | -0.08 | 0.05 | 0.22 | Upgrade
|
| Shareholders' Equity | 777.16 | 405.33 | 197.39 | 196.11 | 239.97 | 416.57 | Upgrade
|
| Total Liabilities & Equity | 1,073 | 640.55 | 362.57 | 273.33 | 287 | 442.06 | Upgrade
|
| Total Debt | 119.14 | 117.19 | 49.89 | 0.8 | 0.79 | 0.68 | Upgrade
|
| Net Cash (Debt) | 879.49 | 516.94 | 308.88 | 269.55 | 283.36 | 438.37 | Upgrade
|
| Net Cash Growth | 659.57% | 67.36% | 14.59% | -4.88% | -35.36% | -9.38% | Upgrade
|
| Net Cash Per Share | 42.42 | 27.66 | 18.02 | 16.30 | 18.34 | 28.48 | Upgrade
|
| Filing Date Shares Outstanding | 21.81 | 19.9 | 18.14 | 17.1 | 16.02 | 15.43 | Upgrade
|
| Total Common Shares Outstanding | 21.81 | 19.88 | 18.1 | 17.1 | 15.51 | 15.43 | Upgrade
|
| Working Capital | 885.82 | 518.73 | 245.48 | 194.85 | 238.61 | 415.07 | Upgrade
|
| Book Value Per Share | 35.64 | 20.39 | 10.90 | 11.47 | 15.47 | 27.00 | Upgrade
|
| Tangible Book Value | 772.34 | 405.33 | 197.39 | 196.11 | 239.97 | 416.57 | Upgrade
|
| Tangible Book Value Per Share | 35.42 | 20.39 | 10.90 | 11.47 | 15.47 | 27.00 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.